Roivant Sciences AOCI decreased by 78.9% to $4.36M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 53.8%, from $9.44M to $4.36M. Over 5 years (FY 2020 to FY 2025), AOCI shows an upward trend with a 24.7% CAGR.
Fluctuations often signal changes in foreign exchange rates, interest rate environments, or pension funding status.
Accumulated Other Comprehensive Income (AOCI) captures the cumulative unrealized gains and losses that are excluded from...
Standard equity component for large multinational corporations with complex balance sheets.
aoci| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.21M | $1.28M | -$1.07M | -$946.00K | $5.02M | $9.09M | -$729.00K | -$2.62M | -$6.61M | -$3.07M | -$27.78M | -$4.08M | -$17.95M | -$18.04M | $8.06M | $9.44M | $17.14M | $19.56M | $20.61M | $4.36M |
| QoQ Change | — | +206.1% | -183.5% | +11.6% | +630.7% | +81.1% | -108.0% | -259.0% | -152.6% | +53.5% | -804.4% | +85.3% | -339.6% | -0.5% | +144.7% | +17.1% | +81.6% | +14.1% | +5.4% | -78.9% |
| YoY Change | — | — | — | — | +515.9% | +609.5% | +31.9% | -176.6% | -231.7% | -133.8% | <-999% | -56.0% | -171.5% | -487.1% | +129.0% | +331.2% | +195.5% | +208.4% | +155.8% | -53.8% |